搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 小时
Dry Age-Related Macular Degeneration Market Set To Grow At An Impressive CAGR Of 8.30% ...
Dry Age-Related Macular Degeneration Market The healthcare landscape in 2025 is poised for a transformative shift, driven by innovation and ...
Medscape
7 天
Both High and Low HDL Levels Linked to Increased Risk for Age-Related Macular Degeneration
High and low levels of high-density lipoprotein and a novel single-nucleotide polymorphism were found to be associated with ...
5 天
on MSN
Both high and low HDL levels are linked to age-related macular degeneration risk
University of California San Diego researchers have identified a U-shaped association between high-density lipoprotein (HDL) ...
Pharmabiz
3 小时
Health Canada authorizes Roche’s Vabysmo pre-filled syringe for three leading causes of ...
Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...
10 天
on MSN
Precision gene editing could prevent vision loss from Stargardt disease
Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...
GEN
11 天
Base Editing Addresses Inherited Macular Degeneration in Primate, Human Tissue Models
The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no ...
Interesting Engineering on MSN
22 小时
New smartglasses use insect vision tech to restore full 3D visual experience
SolidddVision Smartglasses mimic a fly's eye structure to fill in missing vision for macular degeneration sufferers.
FIU News
3 天
Promising new drug candidate for Alzheimer’s
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
ophthalmologytimes
2 天
InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire ...
InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...
1 天
EQS-News: Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea ...
EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈